🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Insilico Medicine and Rallybio for being named Innovation Honorees in FiercePharma's 2024 Fierce 50. Learn more: ▪️ Insilico Medicine - bit.ly/3BcbHyJ ▪️ Rallybio - bit.ly/4gpWJWg #pharma #healthcare #drugdevelopment

Congratulations to Centivo on securing your latest round of financing. This capital will accelerate their mission of delivering high-quality, affordable #healthcare to working families. Learn more: bit.ly/3ZCqAon

Congratulations to XairaTherapeutics and Metsera for being recognized as winners in this year's Endpoints 11. The Endpoints News list highlights #biotech #startups leveraging AI to transform drug R&D and tackle major diseases, rare conditions, and more. Learn more: bit.ly/4eIaqOK

This summer, F-Prime Capital was excited to welcome a talented group of interns and fellows to our Cambridge office. Discover what it's like to be part of our #internship and #fellowship programs: bit.ly/4eiXEpU

Attention #biotech entrepreneurs and researchers! Don’t miss your chance to pitch your #startup ideas at #Science2Startup 2025 to top biotech and #pharma executives, VCs, and entrepreneurs in the Boston area. Applications are due Fri, Nov 15th: bit.ly/4dqXc7P

Congrats to SPRY Therapeutics on securing your latest round of funding. Through this round of funding, they will be looking to build additional products for the global market in addition to expanding their U.S. sales and servicing team. Learn more: bit.ly/403aKDD

Congratulations to David Baker, Co-Founder of Sana Biotechnology, XairaTherapeutics, and CHARM Therapeutics, on being awarded the 2024 #Nobel Prize in Chemistry “for computational protein design.” Learn more: bit.ly/3TM8oVs #Biotech #Healthcare #Innovation

Congratulations to the entire Shift Bioscience team on successful completion of your Seed funding. The investment will accelerate the development of their AI cell simulation platform and support the creation of an IP portfolio. Learn more: bit.ly/3A30PDf

🎙️ Check out the latest BioHub Podcast episode! Host Max Brennan chats with Martin Taylor on his journey from the lab to #VentureCapital and the future of #biotech. Listen here: ◼️ Spotify: bit.ly/3NuJvu2 ◼️ YouTube: bit.ly/3Y7C1C7

Congratulations to AvenCell on your $112 Million Series B financing. This recent funding will facilitate the continued clinical validation of AvenCell’s proprietary switchable universal CAR-T #celltherapy platform. Learn more: bit.ly/4fcNkjm #healthcare #oncology

This month on Fintech Prime Time, we’ve got a quick preview of our next subsector deep dive with Sarah Lamont, while Abdul Abdirahman takes a look at how falling interest rates have affected publicly traded #fintech companies. Learn more: bit.ly/48rZaEc

Join host firms F-Prime Capital, Atlas Venture, 5AM Ventures, Osage Univ. Partners, and RA Capital Management for the 2025 #Science2Startup symposium on Wed, May 14th! Have a groundbreaking idea for a #biotech #startup? Submit your application by Fri, Nov 15th: bit.ly/4dqXc7P

Time is running out! #Science2Startup 2025, on May 14, provides research applicants the chance to receive mentorship from #biotech and #pharma leaders. Submit your application by November 15, to pitch your innovative #startup ideas to industry experts: bit.ly/4dqXc7P

We're so excited to participate in Alluvial's latest $4.3M funding round! The team will use this funding to accelerate institutional staking adoption and expand access to Liquid Collective. Check out the full announcement here: alluvial.finance/strategic-fina…

We're super excited for Notabene as they announce their $14.5M Series B today, led by DRW. Since we co-led the Series A alongside Jump Capital, the crypto pre-trade compliance startup has gone from strength to strength. Read more from Pelle Brændgaard: linkedin.com/pulse/building…

We’re excited to share the latest installment of our “Pioneering Progress” series, now live, highlighting the inspiring journey behind Lenmeldy — a groundbreaking achievement from our portfolio company, Orchard Therapeutics - U.S.. Learn more: bit.ly/4ewf7KR #healthcare #innovation

Congratulations to AtalantaTx on your Series B financing! Atalanta Therapeutics is a #biotech company developing treatments for intractable diseases of the central nervous system using RNA interference. Learn more: bit.ly/4hg8UVv

🎉 Congratulations to Metsera Inc. on your Nasdaq IPO! 🚀 We are excited to celebrate this milestone with you and are proud to support your work to accelerate the next generation of medicines for obesity and metabolic diseases. $MTSR #Healthcare #Biopharma #Obesity

Last week, we hosted a table at the 2025 BioIndustry Association (BIA) Gala and gathered our UK life sciences ecosystem for an evening of cocktails and conversation in London. It was great to see new and familiar faces and foster relationships across science and medicine. #BIAGalaDinner #healthcare

F-Prime is honored to be named as a top investor for #GenAI & #mentalhealth in Galen Growth's 2024 report of the Health Tech 50 Core Investors. #HealthTech 50 report provides a deep dive into the top investors revolutionizing the digital health landscape: bit.ly/3Q3y267